Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Frederick Jeffrey Brown is active.

Publication


Featured researches published by Frederick Jeffrey Brown.


Bioorganic & Medicinal Chemistry Letters | 2000

The discovery of non-basic atrial natriuretic peptide clearance receptor antagonists. Part 1

Chris Allan Veale; Vernon Alford; David Aharony; Debra L. Banville; Russell Bialecki; Frederick Jeffrey Brown; James R. Damewood; Cathy Dantzman; Philip D. Edwards; Robert Toms Jacobs; Russell C. Mauger; Megan Murphy; Willam E Palmer; Kara K. Pine; William L. Rumsey; Laura E Garcia-Davenport; Andrew Shaw; Gary Steelman; Jean M. Surian; Edward P. Vacek

The cyclic peptide ANP 4-23 and the linear peptide analogue AP-811 have been shown to be selective ANP-CR antagonists. Via alanine scanning and truncation studies we sought to determine which residues in these molecules were important in their binding to the clearance receptor and the relationship between these two molecules. These studies show that several modifications to these compounds are possible which improve physical properties of these molecules while retaining high affinity for the ANP-CR.


Journal of Medicinal Chemistry | 1994

Design of Orally Active, Non-Peptidic Inhibitors of Human Leukocyte Elastase

Frederick Jeffrey Brown; Donald W. Andisik; Peter R. Bernstein; Craig Bryant; Chris Ceccarelli; James R. Damewood; Philip Duke Edwards; Roger Earley; Scott W. Feeney


Journal of Medicinal Chemistry | 1997

Orally Active Trifluoromethyl Ketone Inhibitors of Human Leukocyte Elastase

Chris Allan Veale; Peter R. Bernstein; Claudia M. Bohnert; Frederick Jeffrey Brown; Craig Bryant; James R. Damewood; Roger Earley; Scott W. Feeney; Philip Duke Edwards; Bruce Gomes; James Hulsizer; Ben J. Kosmider; Robert D. Krell; Gary Moore; Theodora W. Salcedo; Andrew Shaw; David S. Silberstein; Gary Steelman; Mark Morris Stein; Anne M. Strimpler; Roy M. Thomas; Edward P. Vacek; Joseph C. Williams; Donald John Wolanin; Sheila Woolson


Journal of Medicinal Chemistry | 1990

A novel series of selective leukotriene antagonists: exploration and optimization of the acidic region in 1,6-disubstituted indoles and indazoles.

Ying K. Yee; Peter R. Bernstein; Edward J. Adams; Frederick Jeffrey Brown; Laura A. Cronk; Kevin C. Hebbel; Edward P. Vacek; Robert D. Krell; David W. Snyder


Journal of Medicinal Chemistry | 1989

Hydroxyacetophenone-derived antagonists of the peptidoleukotrienes

Frederick Jeffrey Brown; Peter R. Bernstein; Laura A. Cronk; David L. Dosset; Kevin C. Hebbel; Thomas P. Maduskuie; Howard S. Shapiro; Edward P. Vacek; Ying K. Yee


Journal of Medicinal Chemistry | 1996

N-Aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: KATP Potassium Channel Openers. Modifications on the Western Region

Cyrus John Ohnmacht; Keith Russell; James Roy Empfield; C.A. Frank; Keith Hopkinson Gibson; Daniel Ray Mayhugh; Frances M. Mclaren; Howard S. Shapiro; Frederick Jeffrey Brown; Diane Amy Trainor; Christopher Ceccarelli; Margaret M. Lin; Brian B. Masek; Janet Marie Forst; Robert Joseph Harris; James Hulsizer; Joseph James Lewis; Stuart M. Silverman; Reed W. Smith; Paul James Warwick; Sen T. Kau; Alexa L. Chun; Thomas L. Grant; Burton B. Howe; Jack H. Li; Shephali Trivedi; Tracy J. Halterman; Christopher Yochim; Martin C. Dyroff; M. Kirkland


Journal of Medicinal Chemistry | 1993

Substituted 3-(phenylmethyl)-1H-indole-5-carboxamides and 1-(phenylmethyl)indole-6-carboxamides as potent, selective, orally active antagonists of the peptidoleukotrienes.

Robert Jacobs; Frederick Jeffrey Brown; Laura A. Cronk; David Aharony; Carl K. Buckner; Edward J. Kusner; Karin Kirkland; Kathleen L. Neilson


Journal of Medicinal Chemistry | 1992

1,3,6-trisubstituted indoles as peptidoleukotriene antagonists: benefits of a second, polar, pyrrole substituent.

Frederick Jeffrey Brown; Laura A. Cronk; David Aharony; David W. Snyder


Archive | 1994

1,4-benzoxazine derivatives as potassium channel openers

Frederick Jeffrey Brown; Keith Russell; Paul James Warwick


Archive | 1994

2-fluoroalkyl-1,4-benzoxaxines as potassium channel mediators

Frederick Jeffrey Brown; Keith Russell; Paul James Warwick

Collaboration


Dive into the Frederick Jeffrey Brown's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daniel W. Rosenberg

University of Connecticut Health Center

View shared research outputs
Top Co-Authors

Avatar

John C. McGiff

New York Medical College

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge